VIRTUAL TRADE SHOW BOOTH
Hybrid AF™ Convergent Therapy
More than 2X as effective at stopping atrial arrhythmia versus endocardial RF ablation alone.*
Learn more about this therapy:
Did you know?
Downloadable resources:
*Data based on the post-hoc analysis of long-standing persistent AF sub-groups (N=65)
Based on 7-day continuous rhythm monitoring at 18-months post procedure
DISCLAIMER: AtriCure products available in US may have different indications and intended uses than those AtriCure products available outside the US. This site includes AtriCure products with US approved/cleared intended uses/indications available for sale within the US.